Showing results (181-190 of 352) with videos related to
Sort By:
Pageof 36
Journal of Clinical Pharmacology|March 1, 1992
Effect of the anti-inflammatory agent tenidap on the pharmacokinetics and pharmacodynamics of prednisoloneV Garg, R Blum, K D Wilner, et al.Pharmaceutical Research|September 25, 1999
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteersJ V Gobburu, H Agersø, W J Jusko, et al.Journal of Pharmaceutical Sciences|January 6, 1999
Influence of gender on prednisolone effects on whole blood T-cell deactivation and trafficking in ratsG M Meno-Tetang, J V Gobburu, W J JuskoBritish Journal of Anaesthesia|December 23, 1998
Steady-state propofol brain:plasma and brain:blood partition coefficients and the effect-site equilibration paradoxS Dutta, Y Matsumoto, A Muramatsu, et al.Developmental Pharmacology and Therapeutics|January 1, 1980
Factors affecting theophylline pharmacokinetics in premature infants with apneaD M Hilligoss, W J Jusko, J R Koup, et al.The American Journal of Gastroenterology|March 1, 1980
Bioavailability of hydrocortisone retention enemas in normal subjectsJ J Lima, J Giller, J J Mackichan, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Pharmacokinetics and pharmacodynamics of prednisolone in obese ratsA I Nichols, R D'Ambrosio, N A Pyszczynski, et al.Drug Intelligence & Clinical Pharmacy|July 1, 1983
Procainamide disposition in obesityP B Christoff, D R Conti, C Naylor, et al.Research Communications in Chemical Pathology and Pharmacology|January 1, 1975
Digoxin concentrations in serum and salivaW J Jusko, L Gerbracht, L H Golden, et al.Journal of Clinical Pharmacology|October 1, 1996
Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple dosesG M Ferron, M Rochdi, W J Jusko, et al.Pageof 36